Navigation Links
WHO Issues Caution Against Bird Flu Epidemic

WHO had urged the people to be prepared for any outbreak of Avian Influenza, commonly called bird flu. Although the //disease mainly spreads from birds to other animal species, even to humans, WHO is skeptical that the strain of virus that causes bird flu may soon mutate itself to a form that may spread the disease human to human, and cause an influenza outbreak that human immunity will be unable to handle.

The disease was first seen in the poultry of Republic of Korea in mid December 2003 and had soon spread to Asian countries of Cambodia, China, Indonesia, Japan, Laos, Thailand, and Viet Nam. The first cases of humans being infected by the strain of H5N1 avian influenza were reported in January 2004 in Thailand and Vietnam. In the strong warning issued by FAO of United Nations, it has been pointed out that bird flu will probably remain for a long time in the countries where the disease outbreaks, and hence strong precautionary measures need to be taken to arrest the virus at its roots. In the avian form, the disease is borne by wild birds, especially ducks, and so it may be difficult to contain the spread of the disease. FAO advises that instead of killing the poultry population, it is important to impose strict biosecurity measures to poultry production all over the world.

Link:
http://www.fao.org/newsroom/en/news/2005/89912/index.html
'"/>




Page: 1

Related medicine news :

1. Unsatisfactory Grade On Womens Health Issues
2. Who Board To Discuss Asian Tsunami Related Health Issues
3. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
4. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
5. High Court Issues Notice To Centre On Smoking Ban In Films
6. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
7. China Issues New Legislation To Ban Human Organ Trade
8. Court Issues Order NACO On Gay Issue
9. NGOs and Various Groups Come Together To Address the Issues on AIDS
10. Budhias Medical Report Fails to Address Long Term Health Issues
11. HFEA Issues Warning On Risks Of Multiple Births With IVF
Post Your Comments:
(Date:5/17/2008)...ed Spokesperson for Education Campaign on Behalf o...teinase Inhibitor (Human) Augmentation ..., May 17 /PRNewswire/ -- Melissa Biggs, a fashion,...recently named,spokesperson for an education campa...ans to get tested for alpha-1 antitrypsin (AAT) de...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...g Campaign to Emphasize the Importance of Oral and...ire/ -- National dental insurer United,Concordia D...boration,between Oral Health America and the Briti...nce of oral health to overall health. Beginning Ma... States for the first time,making it the largest ...
(Date:5/16/2008)...s chronic disease sufferers gain benefit from calc...(HealthDay News) -- Taking activated vitamin D may... severe chronic kidney disease by about one quarte...tudy of more than 1,400 patients, those being trea...amin D, had their overall risk of death lowered by...
Breaking Medicine News(10 mins):Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2
...may be the cause of migraines and severe headaches...dy mass //index on frequency, and severity of head...adaches are more common in obese people than those...ers had taken the physical history of the particip...
...ts have found out that increased calcium intake by...may increase the risk of Parkinson’s disease. Park...m. Some of its symptoms are muscle tremors, muscle...ty, stooped posture, slow voluntary movements, and...
...ug AVP-923 is all set to provide relief to people ...clerosis, said the researchers from University of ...s is a chronic neurological disease of the central...he brain and spinal cord and medication till date ...
...was undertaken to find out how to elevate the func...rom arthritis // by the researchers of Feinberg Sc...e study of age 65 yrs and old with arthritis. Func...y to do tasks pertaining to daily living and speci...
Other Medicine News:
(Date:5/15/2008)...acy Clinical Data from Prostate, Colorectal and Ov...Company to Hold Investor Event on Sun., June 1 wit..., May 15 /- Poniard,Pharmac...al company focused,on oncology, today announced th...al trials of picoplatin, in various tumor types an...
(Date:5/15/2008)...ctions demonstrated in Blacks, Hispanics/Latinos, ...dividuals, PARSIPPANY, N.J., May 15 /PRNewswire/ ... presented at the American Society of,Hypertension...08) in New,Orleans demonstrated that the powerful ...an medoxomil) safely and effectively helped,patien...
(Date:5/15/2008).../- CenterWatch, a publishing and,info...h about clinical,trials, finds that investigative ...ic data capture) systems. More than 75% of respond... they had been trained on three or more,EDC system...ctiveness of,their EDC training had improved., St...
(Date:5/15/2008)...ected soon after CEA Trial data reports in third q...RANCISCO, May 15 /- VIA Pha...gy company focused on the development of,compounds...unced today that,it has completed patient enrollme... ACS study is one of three Phase 2 trials investig...
Breaking Medicine Technology:Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Lotus Blossom Consulting Announces E Book on Infertility Treatment Financing 5637 1Lotus Blossom Consulting Announces E Book on Infertility Treatment Financing 5637 2A maternal link to Alzheimers disease 5633 1A maternal link to Alzheimers disease 5633 2A maternal link to Alzheimers disease 5633 3Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diab 770 1Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diab 770 2Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diab 770 3Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS 28R 29 28pioglitazone HCl 29 Slowed t 766 1Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS 28R 29 28pioglitazone HCl 29 Slowed t 766 2Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS 28R 29 28pioglitazone HCl 29 Slowed t 766 3
...SYDNEY, Australia 24 April 2007. Giaconda Ltd (ASX...dministration (FDA) has,approved the Company,s Inv...inical development of MyocondaR to treat patients ...vium spp,paratuberculosis (MAP). , ,The Company un...,first therapy to be submitted to the FDA for this...
... ROCKVILLE, Md., April 18, 2007--Due to water dama...en forced to change the,location for the upcoming ...l 24, 2007 to discuss new drug application for,mar... to be held at,the FDA, Center for Drug Evaluation...Room, 5630 Fishers Lane, in Rockville, MD, the,mee...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: